Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP839034.RAf6z2COJ6_YaUzjl_eZ9yrTItY87Pb4B3h7YzWunPYNo130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP839034.RAf6z2COJ6_YaUzjl_eZ9yrTItY87Pb4B3h7YzWunPYNo130_assertion type Assertion NP839034.RAf6z2COJ6_YaUzjl_eZ9yrTItY87Pb4B3h7YzWunPYNo130_head.
- NP839034.RAf6z2COJ6_YaUzjl_eZ9yrTItY87Pb4B3h7YzWunPYNo130_assertion description "[The epidermal growth factor receptor (EGFR) is a tyrosine kinase (TK) involved in the tumour progression of many cancer types and may serve as an important therapeutic target (erlotinib, cetuximab).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP839034.RAf6z2COJ6_YaUzjl_eZ9yrTItY87Pb4B3h7YzWunPYNo130_provenance.
- NP839034.RAf6z2COJ6_YaUzjl_eZ9yrTItY87Pb4B3h7YzWunPYNo130_assertion evidence source_evidence_literature NP839034.RAf6z2COJ6_YaUzjl_eZ9yrTItY87Pb4B3h7YzWunPYNo130_provenance.
- NP839034.RAf6z2COJ6_YaUzjl_eZ9yrTItY87Pb4B3h7YzWunPYNo130_assertion SIO_000772 20840671 NP839034.RAf6z2COJ6_YaUzjl_eZ9yrTItY87Pb4B3h7YzWunPYNo130_provenance.
- NP839034.RAf6z2COJ6_YaUzjl_eZ9yrTItY87Pb4B3h7YzWunPYNo130_assertion wasDerivedFrom befree-2016 NP839034.RAf6z2COJ6_YaUzjl_eZ9yrTItY87Pb4B3h7YzWunPYNo130_provenance.
- NP839034.RAf6z2COJ6_YaUzjl_eZ9yrTItY87Pb4B3h7YzWunPYNo130_assertion wasGeneratedBy ECO_0000203 NP839034.RAf6z2COJ6_YaUzjl_eZ9yrTItY87Pb4B3h7YzWunPYNo130_provenance.